Progyny sees Q1 revenue of $326.5M, EPS $0.26 with 12-month $27.55 target
Progyny Inc is projected to post Q1 2026 revenue of $326.51 million and EPS of $0.26 when it reports on May 7. Analysts have trimmed full-year 2026 revenue forecasts to $1.38 billion while boosting earnings expectations to $1.18 per share, with a 12-month price target of $27.55 implying 46% upside.
1. Q1 2026 Earnings Preview
Progyny is scheduled to report Q1 2026 results on May 7, with analysts projecting revenue of $326.51 million and earnings per share of $0.26.
2. Estimate Revision Trends
Over the past 90 days, full-year 2026 revenue estimates have been trimmed from $1.40 billion to $1.38 billion and 2027 forecasts cut from $1.55 billion to $1.51 billion, while earnings per share projections rose from $0.94 to $1.18 for 2026 and from $1.14 to $1.39 for 2027.
3. Valuation and Recommendations
Based on 11 analysts, the average 12-month price target is $27.55 (range $19.00–$31.00) implying 46% upside; an internal valuation model suggests $33.09 for a 76% gain. Consensus broker recommendations average 1.8 on a 1–5 scale, signaling an Outperform rating.